From left, Stanley Sy Ming-yiu, the CEO of Sanomics, Dr Yiwu He, chief innovation officer at University of Hong Kong, Ricky Chiu Yin-to, the CEO of Phase Scientific and the SCMP’s senior business reporter, Eric Ng, at the paper’s offices in Causeway Bay on Thursday. SCMP is hosting its China Conference. Photo: May Tse

Hong Kong has research talent and great stock market, but government help is needed to ease local biotech industry’s growth constraints, panel hears

  • There is a gap between the academic and commercial community in Hong Kong, says HKU chief innovation officer
  • Young Hong Kong biotechnology start-ups face funding difficulties: Phase Scientific International
Topic |   Coronavirus China
From left, Stanley Sy Ming-yiu, the CEO of Sanomics, Dr Yiwu He, chief innovation officer at University of Hong Kong, Ricky Chiu Yin-to, the CEO of Phase Scientific and the SCMP’s senior business reporter, Eric Ng, at the paper’s offices in Causeway Bay on Thursday. SCMP is hosting its China Conference. Photo: May Tse
READ FULL ARTICLE